Koers Bionoid Pharma Inc. Other OTC
Aandelen
BINP
US09076D1019
Geavanceerde medische apparatuur & technologie
Omzet 2012 | - | Omzet 2013 | 0,09 0,09 | Marktkapitalisatie | 3,37 mln. 3,16 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | - 0 | Nettowinst (verlies) 2013 | -1 mln. -936K | EV/omzet 2012 | - |
Nettoschuld 2012 | 65,8K 61,56K | Nettoschuld 2013 | 427K 399K | EV/omzet 2013 | 41.184.797 x |
K/w-verhouding 2012 |
15,8
x | K/w-verhouding 2013 |
-3,13
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 0,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Meyers
CEO | Chief Executive Officer | - | - |
Mark Goldhar
DFI | Director of Finance/CFO | 40 | - |
Wayne Cockburn
CHM | Chairman | 66 | 01-09-03 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wayne Cockburn
CHM | Chairman | 66 | 01-09-03 |
Barinder Rasode
BRD | Director/Board Member | - | - |
Dennis Reich
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,33% | 220 mld. | |
+6,54% | 183 mld. | |
+10,18% | 133 mld. | |
+24,92% | 107 mld. | |
-1,63% | 63,05 mld. | |
+12,72% | 51,74 mld. | |
+3,96% | 50,47 mld. | |
+0,11% | 40,91 mld. | |
+24,11% | 31,91 mld. |